Contemporary OB/GYN week in review: maternal syphilis, abortion laws, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: maternal syphilis, abortion laws, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, February 12 - Friday, February 16, 2024), and click each link to read and watch anything you may have missed.
1.) CDC data reveals surge in maternal syphilis rates
The Centers for Disease Control and Prevention's latest report unveils a 222% rise in maternal syphilis cases per 100,000 live births from 2016 to 2022, with increases observed across racial, age, and perinatal care groups nationwide.
Click here for the full article.
2.) Impact of abortion laws on OBGYN residency applications
Recent research suggests strict abortion laws may deter applicants to obstetrics and gynecology residency programs, with implications for medical education and workforce diversity.
Click here for the full article.
3.) Ultrasound method enhances preterm birth risk assessment
A novel ultrasound technique allows for early and accurate prediction of preterm birth risk, potentially revolutionizing prenatal care for first-time pregnant women.
Click here for the full article.
4.) Cefepime–Taniborbactam outperforms meropenem in treating complicated UTI
A recent study demonstrated the superior efficacy of cefepime–taniborbactam over meropenem for managing complicated urinary tract infections, suggesting a promising treatment option amid rising antibiotic resistance challenges.
Click here for the full article.
5.) Safely evaluating penicillin allergy with 2-step Graded Oral Challenge
Recent findings revealed the efficacy and safety of the 2-step Graded Oral Challenge method in assessing penicillin allergy risk, offering a promising approach for improved patient care and antibiotic stewardship in low-risk individuals.
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
